The drug similar to Ozimpic was unable to treat Parkinson’s disease during the process
The idea was so tempting. The drugs in the GLP-1 class, which include Wegovy and Ozempic, have shown themselves miraculous in the treatment of weight loss and other diseases. And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat: those of the brain, such as Parkinson's ones.But now, at least for Parkinson's, that hope seems attenuated. A rigorous study that randomly assigned Parkinson's patients to take Exenatide, a relative of Ozimpic, has not shown absolutely any benefit or slowdown in the course of the degenerative disease after 96 weeks.And there has been no effect on the patient's symptoms, no effect on brain scans, no subgroup that showed any benefit. It doesn't matter how the researchers cut the data, the results were the same.Th...